©The Author(s) 2026.
World J Clin Oncol. Feb 24, 2026; 17(2): 116251
Published online Feb 24, 2026. doi: 10.5306/wjco.v17.i2.116251
Published online Feb 24, 2026. doi: 10.5306/wjco.v17.i2.116251
Table 2 Multivariable logistic regression for pathological complete response
| Variable | Adjusted OR (95%CI) | P value |
| CSC positive | 0.05 (0.01-0.39) | 0.004 |
| Age (per year) | 1.00 (0.97-1.03) | 0.937 |
| Grade (per level) | 1.10 (0.67-1.81) | 0.664 |
| Stage II (vs I) | 1.48 (0.66-3.29) | 0.337 |
| Stage III (vs I) | 1.03 (0.49-2.16) | 0.944 |
- Citation: Depar FN, Chaudhary AJ, Hameed J, Abbasi FS, Uzma B, Ali A, Akhtar N, Khan R, Siddiqi A, Riaz S. Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer. World J Clin Oncol 2026; 17(2): 116251
- URL: https://www.wjgnet.com/2218-4333/full/v17/i2/116251.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i2.116251